- Home
- ARMP vs BARK Comparison
ARMP vs BARK Comparison
Compare ARMP & BARK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- BARK
- Stock Information
- Founded
- ARMP N/A
- BARK 2011
- Country
- ARMP United States
- BARK United States
- Employees
- ARMP N/A
- BARK N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- BARK Department/Specialty Retail Stores
- Sector
- ARMP Health Care
- BARK Consumer Discretionary
- Exchange
- ARMP Nasdaq
- BARK Nasdaq
- Market Cap
- ARMP 125.7M
- BARK 146.0M
- IPO Year
- ARMP N/A
- BARK N/A
- Fundamental
- Price
- ARMP $5.73
- BARK $0.79
- Analyst Decision
- ARMP Strong Buy
- BARK Strong Buy
- Analyst Count
- ARMP 1
- BARK 3
- Target Price
- ARMP $9.00
- BARK $2.50
- AVG Volume (30 Days)
- ARMP 759.0K
- BARK 1.2M
- Earning Date
- ARMP 11-07-2025
- BARK 11-10-2025
- Dividend Yield
- ARMP N/A
- BARK N/A
- EPS Growth
- ARMP N/A
- BARK N/A
- EPS
- ARMP N/A
- BARK N/A
- Revenue
- ARMP $6,868,000.00
- BARK $470,831,000.00
- Revenue This Year
- ARMP $8.43
- BARK N/A
- Revenue Next Year
- ARMP N/A
- BARK $6.25
- P/E Ratio
- ARMP N/A
- BARK N/A
- Revenue Growth
- ARMP 84.67
- BARK N/A
- 52 Week Low
- ARMP $0.90
- BARK $0.73
- 52 Week High
- ARMP $16.34
- BARK $2.56
- Technical
- Relative Strength Index (RSI)
- ARMP 63.43
- BARK 43.39
- Support Level
- ARMP $4.65
- BARK $0.81
- Resistance Level
- ARMP $6.36
- BARK $1.04
- Average True Range (ATR)
- ARMP 1.34
- BARK 0.07
- MACD
- ARMP 0.01
- BARK -0.01
- Stochastic Oscillator
- ARMP 22.25
- BARK 5.18
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About BARK BARK Inc.
BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.